Oramed Pharmaceuticals Stock Discussion

$Oramed Pharmaceuticals (ORMP.US)$
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Tuesday, 11th February at 9:15 am
New Standalone Company, OraTech Pharmaceuticals Inc., to Focus on Oral Drug Delivery with Strategic Investment and Advanced Manufacturing Capabilities
Oramed shareholders to receive the right to a direct stake in OraTech, expected to go public on Nasdaq.
OraTech will have global marketing rights to Oramed's POD™ or...

$Oramed Pharmaceuticals (ORMP.US)$
Oral Insulin Breakthrough: $75M Deal Positions Oramed's Revolutionary Drug Delivery Platform for Global Launch

$Oramed Pharmaceuticals (ORMP.US)$
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the execution of definitive agreements for the restructuring of a portion of its existing Senior Secured Promissory Note from Scilex Holding Compa...

$Oramed Pharmaceuticals (ORMP.US)$ target price $30.00

$Oramed Pharmaceuticals (ORMP.US)$ Can Not Short Better No Buy DELETE 🤗👊👍

$Oramed Pharmaceuticals (ORMP.US)$
your turn tonight?

$Oramed Pharmaceuticals (ORMP.US)$ $2.70 close